A Single Ascending Dose Study of Soluble Ferric Pyrophosphate Administered Intravenously in Healthy Volunteers.
PHASE1CompletedINTERVENTIONAL
Enrollment
48
Participants
Timeline
Start Date
June 30, 2013
Primary Completion Date
September 30, 2013
Study Completion Date
September 30, 2013
Conditions
Kidney Failure, Chronic Therapy; Hemodialysis
Interventions
DRUG
soluble ferric pyrophosphate
DRUG
Placebo
Trial Locations (1)
49007
Kalamazoo
All Listed Sponsors
lead
Rockwell Medical Technologies, Inc.
INDUSTRY
NCT01920854 - A Single Ascending Dose Study of Soluble Ferric Pyrophosphate Administered Intravenously in Healthy Volunteers. | Biotech Hunter | Biotech Hunter